Charts Alterity Therapeutics Limited Nasdaq
Stocks
ATHE
US02155X2053
Biotechnology & Medical Research
|
Market Closed -
Nasdaq
16:30:00 2026-10-08 EDT
|
5-day change | 1st Jan Change | ||
| 3.070 USD | -7.53% |
|
-15.89% | -0.32% |
| 09-16 | Lake Street Initiates Alterity Therapeutics at Buy With $10 Price Target | MT |
| 08-30 | Alterity Therapeutics Enters Underwriting Agreement for Exercise of up to 8.4 Million Listed Options | MT |
Chart: Technical Analysis
NasdaqUSD
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| ATHE | Delayed | |
CBOE
| ATHE | Real-time | |
|
Deutsche Boerse AG
| PBN0 | Delayed | |
|
Börse Stuttgart
| PBN0 | Delayed | |
Australian S.E.
| ATH | Delayed | |
|
OTC Markets
| PRNAF | Delayed | |
|
Deutsche Boerse AG
| PBN | Delayed | |
|
Börse Stuttgart
| PBN | Delayed |
MarketScreener's Technical Analysis Ratings
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Stocks
- ATH Stock
- ATHE Stock
- Charts Alterity Therapeutics Limited
Select your edition
All financial news and data tailored to specific country editions
